Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity

DOI: 10.1128/JVI.02002-20

Article Information

DOI

PubMed

Published By

History

Editors and / or Reviewers

^aCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
^bSydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia
^cFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
^dQIMR Berghofer Centre for Immunotherapy and Vaccine Development, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
^eCentre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
^fMarie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, The University of Sydney, Westmead, New South Wales, Australia
^gCentre for Cancer Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
^hBMT and Cell Therapies Program, Westmead Hospital, Westmead, New South Wales, Australia

Address correspondence to Eunok Lee, eunok.lee{at}sydney.edu.au.
Eunok Lee, Kerrie Sandgren, and Gabriel Duette contributed equally to this article. Author order was determined by the contribution to the results presented in the manuscript and contribution to writing the initial manuscript draft. Anthony L. Cunningham and Sarah Palmer are co-senior authors with equal contributions.
Citation Lee E, Sandgren K, Duette G, Stylianou VV, Khanna R, Eden J-S, Blyth E, Gottlieb D, Cunningham AL, Palmer S. 2021. Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity. J Virol 95:e02002-20. https://doi.org/10.1128/JVI.02002-20.